Immunocore Holdings earnings were -$18.1M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest IMCR earnings report on Jun 30, 2026 announced Q2 2026 earnings of -$808.0k, down 106.2% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, IMCR reported annual earnings of -$35.5M, with -30.5% growth. The next IMCR earnings date is Nov 5, 2026.
Immunocore Holdings Earnings Reports & History FAQ
What were Immunocore Holdings's earnings last quarter?
On IMCR's earnings call on Aug 6, 2026, Immunocore Holdings (NASDAQ: IMCR) reported Q2 2026 earnings per share (EPS) of -$0.02, up 90% year over year. Total IMCR earnings for the quarter were -$808.00 thousand. In the same quarter last year, Immunocore Holdings's earnings per share (EPS) was -$0.20.
The next IMCR earnings call is Nov 5, 2026. Add IMCR to your watchlist to be reminded of Immunocore Holdings's next earnings date.
Is Immunocore Holdings profitable or losing money?
As of the last Immunocore Holdings earnings report, Immunocore Holdings is currently losing money. Immunocore Holdings's net profit (also called net income) for the twelve months ending Jun 30, 2026 was -$18.07 million, a 11.02% decrease year over year.
What was IMCR's earnings growth in the past year?
As of Immunocore Holdings's earnings date in Aug 6, 2026, Immunocore Holdings's earnings has grown year over year. IMCR earnings in the past year totalled -$18.07 million.
What are Immunocore Holdings's earnings expectations?
The current EPS estimate for Immunocore Holdings's earnings report in Nov 5, 2026 is -$0.10.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.